CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Venturini et al. (2007) showed that compared to normal CD34+ cells, CD34+ cells in the early chronic phase of CML had significantly higher expression levels of the miR-17-92 cluster genes.